|
Volumn 508, Issue 7497, 2014, Pages 439-440
|
Tamiflu report comes under fire.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
OSELTAMIVIR;
SIALIDASE;
ZANAMIVIR;
DRUG ANTAGONISM;
DRUG EFFECT;
ECONOMICS;
ENZYMOLOGY;
HEALTH CARE PLANNING;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A H5N1;
METABOLISM;
NOTE;
OBSERVATIONAL STUDY;
PATHOGENICITY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ANTIVIRAL AGENTS;
HUMANS;
INFLUENZA A VIRUS, H5N1 SUBTYPE;
INFLUENZA, HUMAN;
NEURAMINIDASE;
OBSERVATIONAL STUDY AS TOPIC;
OSELTAMIVIR;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
STRATEGIC STOCKPILE;
ZANAMIVIR;
|
EID: 84902172515
PISSN: None
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/508439a Document Type: Note |
Times cited : (15)
|
References (0)
|